Research use only, not for human consumption. Email [email protected]
← Research status explorer
Peak / Growth axis

Sermorelin

Also known as: Geref

Current research status Human Research
Extensive historical human research
Preclinical
Human Research

Overview

Sermorelin is a GHRH(1-29) fragment analogue with a long history of human research and, historically, prior US regulatory approval (as Geref) before that product was discontinued. Substantial published human data exist from that earlier era, though sermorelin is not currently marketed as an FDA-approved product.

Last reviewed: September 2026